NEW YORK, May 14, 2018 /PRNewswire/ -- Global Radiodermatitis Market: OverviewRadiodermatitis, also known as radiation dermatitis, is a peculiar symptom caused as a result of radiation therapy pertaining to the treatment of cancerous as well as noncancerous conditions, and has significant negative impact on a patient's physical functionalities and quality of life. It has been estimated that in developed countries such as the U.S., Canada, Australia, the U.K, France, and Germany, nearly half of the patients who receive treatment for cancer was also subjected to radiation therapy during the illness, and about all of them experience some degree of skin reaction. As the cases of cancer escalates across the world, the demand in the global radiodermatitis is expected to increment at a considerable CAGR of 3.93% during the forecast period of 2017 to 2024.Read the full report: https://www.reportlinker.com/p04268679
This report, developed by a group of professional market research analysts, aspires to serve as a credible business tool for the stakeholders of this market.The report studies the prospects of various segments of the market, based on product, distribution channel, and geography, as well as profiles a number of leading players to understand the competitive landscape.Qualitative and quantitative assessment of all factors that may influence the demand for radiodermatitis has been provided in the report.Global Radiodermatitis Market: Trends & OpportunitiesAccording to the International Agency for Research on Cancer (IARC), there were 14.1 million new cases of cancer across the world, and the figure is estimated to reach up to 21.7 million by the end of 2030. This substantial patient volume is the primary driver of the global radiodermatitis market. In addition to that, increasing focus on product innovation as well as advancements in the existing products are also expected to favor the market in the near future. Growing number of private and public healthcare organizations, who are constantly trying to promote the awareness regarding radiodermatitis treatment and management, and rising number of clinical studies to evaluate the efficiency of radiodermatitis treatment are some of the other factors favoring the global radiodermatitis market.Based on product, the global radiodermatitis market has been segmented into topical, oral medication, and dressings.While topical segment is sub-segmented into hydrophilic creams, corticosteroids, and others such as antibiotics, oral medical is further divided into corticosteroids and others such as antibiotics and oral analgesics, whereas dressing segment is further categorized into hydrogel, no sting barrier film, hydrocolloid, honey impregnated gauze, silicone coated dressing, and others such as silver leaf dressing and GM-CSF gauze.On the basis of dressing channel, the market has been bifurcated into hospital pharmacy, online store, and retail pharmacy store.Global Radiodermatitis Market: Regional OutlookThough the demand for radiodermatitis is growing in all regions across the globe, Asia Pacific currently serves the maximum demand, owing to higher percentage untapped patient-base.A number of emerging economies in the Asian region are situated in tropical region with humid weather conditions, in which the effect of radiation dermatitis is quite high.Extensive collaborations among the key players in order to increase their product portfolio and involvement of well-established pharmaceutical companies in this region on commercialization of their products are also expected to help them increment their shares in this region.Companies mentioned in the research reportSmith & Nephew plc, 3M Healthcare, Acelity, Convatec, Inc., and Molnlycke Health Care are some of the key companies operating in this market.Key Segments of the Global Radiodermatitis MarketGlobal Radiodermatitis Market, by ProductTopicalCorticosteroidsHydrophilic CreamsOthers (topical antibiotics)Oral MedicationCorticosteroidsOther (oral analgesics, antibiotics, etc.)DressingsHydrogelHydrocolloidNo Sting Barrier FilmHoney Impregnated GauzeSilicone Coated DressingOthers (GM-CSF gauze, silver leaf dressing, etc.)Global Radiodermatitis Market, by Distribution ChannelHospital PharmacyRetail Pharmacy StoreOnline StoreGlobal Radiodermatitis Market, by GeographyNorth AmericaU.S.CanadaAsia PacificChinaJapanRest of APACEuropeU.K.GermanyRest of EuropeLatin AmericaBrazilMexicoRest of Latin AmericaMiddle East & AfricaUAESouth AfricaRest of Middle East & AfricaThis report gives you access to decisive data such as:Market growth driversFactors limiting market growthCurrent market trendsMarket structureMarket projections for the coming yearsKey highlights of this reportOverview of key market forces propelling and restraining market growthUp-to-date analyses of market trends and technological improvementsPin-point analyses of market competition dynamics to offer you a competitive edgeAn analysis of strategies of major competitorsAn array of graphics and SWOT analysis of major industry segmentsDetailed analyses of industry trendsA well-defined technological growth map with an impact-analysisOffers a clear understanding of the competitive landscape and key product segmentsRead the full report: https://www.reportlinker.com/p04268679
About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place. __________________________ Contact Clare: [email protected]
US: (339)-368-6001 Intl: +1 339-368-6001
Advertisement
View original content:http://www.prnewswire.com/news-releases/radiodermatitis-market---global-industry-analysis-size-share-growth-trends-and-forecast-2017---2024-300647674.html
SOURCE Reportlinker
